Did ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) beat earnings estimates last quarter?
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) missed EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:ZYBT • KYG989MS1016
Past quarterly earnings results for ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in CNY): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | - | - | 62.328M | - | -34.36% | |||
| Q4 2024 | - | - | 186.356M | - | -11.95% | |||
| Q2 2024 | - | - | 94.949M | - | 81,122.41% | |||
| Q4 2023 | - | - | 211.651M | - | - | |||
| Q2 2023 | - | - | 116.9K | - | - |
Notes
ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) missed EPS estimates and missed revenue estimates in the most recent quarter.